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A total of 84 nasopharyngeal swab specimens were collected from 84 patients. Viral nucleic acid was extracted by three automated
extraction systems: QIAcube (Qiagen, Germany), EZ1 Advanced XL (Qiagen), and MICROLAB Nimbus IVD (Hamilton, USA).
Fourteen RNA viruses and two DNA viruses were detected using the Anyplex II RV16 Detection kit (Seegene, Republic of Korea).
TheEZ1AdvancedXL systemdemonstrated the best analytical sensitivity for all the three viral strains.Thenucleic acids extracted by
EZ1AdvancedXL showedhigher positive rates for virus detection than the others.Meanwhile, theMICROLABNimbus IVD system
was comprised of fully automated steps from nucleic extraction to PCR setup function that could reduce human errors. For the
nucleic acids recovered from nasopharyngeal swab specimens, the QIAcube system showed the fewest false negative results and the
best concordance rate, and it may bemore suitable for detecting various viruses including RNA andDNA virus strains. Each system
showed different sensitivity and specificity for detection of certain viral pathogens and demonstrated different characteristics such
as turnaround time and sample capacity. Therefore, these factors should be considered when new nucleic acid extraction systems
are introduced to the laboratory.
1. Introduction
Respiratory viruses can cause mild to severe illnesses as
well as frequent complications. They frequently cause pneu-
monia in children, especially those younger than 2 years
(up to approximately 80%) [1, 2]. For adult patients in
the ICU, these pathogens account for 28% of pneumonia
cases, with mortality rates comparable to those of bacterial
pneumonia [3]. The mean annual incidence of respiratory
tract infections in the United States was reported to be 4.2
and 1.2 for the first and the second years of a child’s life,
respectively. Furthermore, 27% of respiratory tract infections
resulted from coinfectionwith two ormore viruses, including
rhinovirus, human coronavirus, and adenovirus [4]. Since
the year 2000, many new respiratory viruses have been
identified including H5N1 avian influenza, SARS-coronavi-
rus, human coronavirus NL63, human coronavirus HKU1,
human metapneumovirus, human bocavirus, and human
rhinovirus type C [5, 6]. Therefore, simultaneous identifica-
tion of multiple viruses is needed for timely patient manage-
ment.
Detection or characterization of the respiratory viruses by
conventional diagnostic techniques such as cell culture, direct
fluorescent antibody detection (DFA), and serological testing
can be difficult and time-consuming [7–9]. Thus, rapid
and highly accurate PCR methods have been numerously
evaluated and multiplex real-time (RT)-PCR method is cur-
rently considered as the best technique for the detection and
typing of comprehensive panel formany common respiratory
viruses [7, 10, 11].
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High-quality nucleic acid extraction is necessary for the
multiplex RT-PCR assays as the results are greatly influenced
by the nucleic acid quality [12, 13]. As the conventional
manual nucleic acid extraction methods are prone to con-
tamination and inter- and intraoperator variability [14, 15],
various automated nucleic acid extractionmethods have been
introduced.
Some automated nucleic acid extraction systems includ-
ing the easyMGA system (Biome´rieux), the Qiasymphony
(Qiagen), Biorobot EZ1, and MgaNA pure Compact (Roche)
were evaluated for stool, nasal, and nasopharyngeal aspirate
samples in previous study [16–18]. However, these automated
nucleic acid extraction systems were evaluated using mul-
tiplex PCR or multiples real-time PCR assays which are
capable of detecting only up to 5 viruses simultaneously in
a single patient sample. Only recently, multiple real-time
PCR assay which is capable detecting more than 14 viruses
simultaneously was developed and widely used [19, 20]. But a
comprehensive comparison of the automated extraction sys-
tems for these multiplex RT-PCR using nasopharyngeal aspi-
rate samples has never been carried out. The EZ1 Advanced
XL and the QIAcube systems have been popularly used
in medical laboratories for DNA/RNA extraction, whereas
the MICROLAB Nimbus IVD system is newly introduced.
Therefore, we evaluated the three different automated nucleic
acid extraction systems for multiplex RT-PCR using clinical
nasopharyngeal swab specimens.
2. Materials and Methods
2.1. Clinical Specimen Collection. A total of 84 nasopharyn-
geal swabs (Universal Transport Medium, Copan Diagnos-
tics, Murrieta, CA, USA) were collected from 20 adult and
64 pediatric patients with signs and/or symptoms of the
respiratory infection between February and July, 2012. All
specimens were stored at 2–8∘C for up to 72 hours prior
to processing. The study was approved by the Institutional
Review Boards of Gangnam Severance Hospital.
2.2. Nucleic Acid Extraction. Three different automated sys-
tems were used for the nucleic acid extraction. QIAcube
system (Qiagen, Hilden, Germany) with QIAamp MinElute
Virus Spin Kit (Qiagen), EZ1 Advanced XL system (Qiagen)
with EZ1 Advanced XL Virus Mini kit v2.0 (Qiagen), and
MICROLAB Nimbus IVD system (Hamilton, Reno, NV,
USA) with STARMag96 Virus kit (Seegene, Seoul, Korea)
were evaluated. Three aliquot samples were separated from
each of the specimens, and nucleic acid of each aliquot
samples was extracted on the same day by three different
automated systems in a single laboratory. The sample and
elution volumes used in this study were 150𝜇L and 60 𝜇L for
the QIAcube system, 400 𝜇L and 60 𝜇L for the EZ1 Advanced
XL system, and 600 𝜇L and 100 𝜇L for the MICROLAB
Nimbus IVD system, respectively. For the quality control
of the entire nucleic acid extraction process and RT-PCR,
10 𝜇L of bacteriophage MS2 (AnyplexTMII RV16 detection,
Seegene) was added to each sample as the internal control in
order to check the entire process from nucleic acid extraction
to PCR. cDNA was synthesized using the cDNA Synthesis
Premix (Seegene) which included reverse transcriptase and a
random hexamer, according to the manufacturer’s protocol.
2.3. Real-Time PCR and Melting Curve Analysis. Anyplex
II RV16 Detection kit (Seegene) was used to detect 14
RNA viruses and 2 DNA viruses including human ade-
novirus (ADV), influenza A and B viruses (FluA, FluB),
human parainfluenza viruses 1/2/3/4 (PIV1/2/3/4), human
rhinovirus A/B/C (RV A/B/C), human respiratory syncy-
tial viruses A and B (RSV-A, RSV-B), human bocaviruses
1/2/3/4 (BoV1/2/3/4), human coronaviruses 229E, NL63 and
OC43 (CoV-229E, CoV-NL63, CoV-OC43), human metap-
neumovirus (MPV), and human enterovirus (EV). A real-
time PCR reaction mixture was prepared with as follows:
8 𝜇L cDNA, 4 𝜇L 5x RV primer, 4 𝜇L 8-methoxypsoralen
solution, and 4 𝜇L 5x Master Mix. Seegene’s unique real-time
PCR and melting curve analysis technique called “Tagging
Oligonucleotide Cleavage and Extension” assay (http://www
.seegene.co.kr/neo/en/introduction/core toce.php) was per-
formed using CFX96 real-time PCR detection system (Bio-
Rad, Hercules, CA, USA) as follows: (1) 1 cycle of initial
denaturation at 95∘C for 15min, (2) 50 cycles of denaturation
at 94∘C for 30 sec, annealing at 60∘C for 1min, and extension
at 72∘C for 30 sec, (3) 1 cycle of cooling the reaction mixture
at 55∘C for 30 sec, and (4) melting double-stranded DNA
into single strands by raising the temperature to 85∘C.
The fluorescence was measured continuously during the
temperature rise from 55∘C. And, the melting peaks were
derived from the initial fluorescence (𝐹) versus temperature
(𝑇) curves by plotting the negative derivative of fluorescence
over temperature versus temperature (−𝑑𝐹/𝑑𝑇 versus 𝑇) by
Seegene software [19]. If internal control was not detected in
real-time PCR reaction, the results were sorted as “invalid
results” by Seegene software. Plasmids containing the target
sequence were included as positive controls.
2.4. Analytical Sensitivity of the Automated Nucleic Acid
Extraction Systems. One DNA (ADV) and 2 RNA (RSV-A
and FluA) viral reference strains (ATCC VR-3, ADV; ATCC
VR-26, RSV-A; ATCC VR-544, FluA) were obtained from
the Korean Bank for Pathogenic Viruses (Korea University
College ofMedicine, Seoul, Republic of Korea).The reference
strains were serially diluted with 10-fold saline buffer and
they were made as five-level samples: ADV (10−6 to 10−10),
FluA (10−5 to 10−9), and RSV (10−4 to 10−8). And each diluted
sample was extracted 5 times using the 3 different automated
nucleic acid extraction systems.
2.5. Interpretation of the Results. When all 2 or 3 of the
automated nucleic acid extraction systems yielded the same
results, they were considered as a true positive and we
considered it as a true negative when all 3 of the automated
nucleic acid extraction systems yielded “not detected.” In case
of positive results from only 1 of the three automated nucleic
acid extraction systems, the confirmatory test performed
with the Seeplex RV15 ACE Detection kit (Seegene). When
the confirmatory test also yielded negative result, it was
BioMed Research International 3
Table 1: Distribution of respiratory viruses in 44 positive nasopharyngeal swab specimens.
Virus type Single infection
(𝑛 = 33)
Dual infection
(𝑛 = 8)
Triple infectiona
(𝑛 = 3)
Total (%)
(𝑛 = 44)
RV 10 7 2 19 (32.8)
MPV 3 2 3 8 (13.8)
PIV3 5 2 1 8 (13.8)
RSV-A 6 1 0 7 (12.1)
ADV 1 2 2 5 (8.6)
FluB 2 0 1 3 (5.2)
FluA 2 0 0 2 (3.4)
BoV 1 1 0 2 (3.4)
EV 1 1 0 2 (3.4)
CoV-OC43 1 0 0 1 (1.7)
PIV1 1 0 0 1 (1.7)
Total (%) 33 (56.9) 16 (27.6) 9 (15.5) 58 (100.0)
aRV + MPV + ADV (𝑛 = 1), RV + MPV + FluB (𝑛 = 1) and MPV + ADV + PIV3 (𝑛 = 1).
RV: human rhinovirus; MPV: human metapneumovirus; PIV3: human parainfluenza virus 3; RSV-A: human respiratory syncytial virus A; ADV: human
adenovirus; FluB: influenza B; FluA: influenza A; BoV: human bocavirus; EV: human enterovirus; CoV-OC43: human coronavirus OC43; PIV1: human
metapneumovirus.
considered as a false positive [16]. Among these positive
results from only 1 of the three automated nucleic acid
extraction systems, three pathogens (FluB, HRV, and HBoV)
were detected when repeated with the Seeplex RV15 ACE
Detection kit (Seegene). These discordant results were also
confirmed by PCR and sequencing. The following primers
were used for the sequencing analysis: FluB-NF (GTC CAT
CAA GCT CCA GTT TT), FluB-NR (TCT TCT TAC AGC
TTG CTT GC) (145 bp), HRV-5󸀠NCRF (GCA CTT CTG
TTT CCC C), HRV-5󸀠NCRR (CGG ACA CCC AAA GTA
G) (380 bp), HBoV-NP1F (GAC CTC TGT AAG TAC TAT
TAC), HBoV-NP1R (CTC TGT GTT GAC TGA ATA CAG)
(354 bp) [21].
2.6. Statistical Analysis. Statistical analysis was performed
using SPSS Statistics 20.0 (SPSS Inc., Chicago, IL, USA)
and Analyse-it 2.22 (Analyse-it Software Ltd., Leeds, UK).
Kappa coefficients were calculated to estimate the agreement
between the results by different utilized methods.
3. Results
3.1. Detection of Respiratory Viruses in Clinical Speci-
mens. Among the 84 nasopharyngeal swab specimens, viral
pathogens were detected in 44 specimens (detection rate:
52.4%). A total of 58 pathogens including multiple infections
were detected in 44 specimens and the proportions of single
and dual and triple infections were 75.0%, 18.2% and 6.8%,
respectively. Based on frequency of detection, RV (32.8%)
was more than one-third of detected pathogens, followed by
MPV (13.8%), PIV3 (13.8%), RSV-A (12.1%), andADV (8.6%).
And RVwas the predominant pathogen in case of both single
(30.3%, 𝑛 = 10/19) and dual (87.5%, 𝑛 = 7/8) respiratory
infections (Table 1).
3.2. Comparison of the PCR Results from 3 Automated
Nucleic Acid Extraction Systems. The numbers of positives
for respiratory viruses ranged from 54 to 59. The nucleic
acids extracted by EZ1 Advanced XL showed higher pos-
itive rates for virus detection than the others. Among the
discrepant results, three positive nucleic acid extracts, which
were obtained by only one of the three automated nucleic
acid extraction systems, were confirmed by sequencing. Two
positive nucleic acid extracts including RV (𝑛 = 1) and
BoV (𝑛 = 1) were obtained by the QIAcube system, while
one FluB positive nucleic acid extract was obtained with
EZ1 Advanced XL (Table 2). On the basis of Section 2.5,
sensitivity, specificity, concordance rate, and kappa coefficient
for the 3 automated nucleic acid extraction systems are shown
in Table 3. The percent sensitivity and specificity of the 3
systems ranged from 87.2% to 93.3% and from 82.9% to
94.6%, respectively. The concordance rates between the true
results and the 3 systems ranged from 88.3% to 94.2%. The
kappa coefficients ranged from 0.76 to 0.88 (𝑃 < 0.001
for all values). The QIAcube system yielded the best percent
sensitivity and concordance rate, while the MICROLAB
Nimbus IVD system demonstrated the lowest sensitivity and
the highest specificity. Sensitivity and specificity of the 3
systems were also evaluated for the most commonly detected
5 viral pathogens. The QIAcube system showed the highest
sensitivity for the RNA viruses (RV, MPV, PIV3, and RSV-
A), while the EZ1 Advanced XL system demonstrated the best
percent sensitivity for the ADV.
One of two BoVs was not detected by the EZ1 Advanced
XL system, while all three were detected by the QIAcube
system (Table 2). For DNA viruses, including ADV and
BoV, the QIAcube system and the EZ1 Advanced XL system
demonstrated equal sensitivity of 85.7%.
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Table 2: Comparison of detection of respiratory virus by three automatic extraction methods from nasopharyngeal swab specimens.
Virus QIAcube EZ1 advanced XL MICROLAB Nimbus IVD Total number of specimens
RV
+ + + 14
+ − + 3
+ − − 1a
− + + 1
− + − 2b
MPV + + + 7
+ + − 1
PIV3 + + + 8
PIV1 + + + 1
− + − 1b
PIV4 + − − 1b
RSV-A + + + 7
− + − 1b
ADV
+ + + 2
− + + 1
+ + − 2
− + − 3b
FluB + + + 2
− + − 1a
FluA + + + 2
BoV + + + 1
+ − − 1a
EV + + + 2
+ − − 1b
CoV-OC43 1 1 1 1
CoV-NL63 − − + 1b
CoV-229E − − + 1b
Total 57 59 54 68
aVirus detected by only 1 of the three automated nucleic acid extraction systems, and we confirmed this result by sequencing analysis and confirmed it as “true
positive.”
bVirus detected by only 1 of the three automated nucleic acid extraction systems, but they were not detected by repeated test with the Seeplex RV15 ACE
Detection kit (Seegene).
3.3. Characteristics of the Three Automated Nucleic Acid
Extraction Systems. Basic characteristics of the 3 automated
nucleic acid extraction systems are summarized in Table 3.
The QIAcube system employs the spin column principle,
while the EZ1 Advanced XL and the MICROLAB Nimbus
IVD systems use magnetic particles for the nucleic acid
extraction.While sample and elution volumes can be adjusted
in the QIAcube and the EZ1 Advanced XL systems, they
are fixed in the MICROLAB Nimbus IVD system. The EZ1
Advanced XL system demonstrated the shortest turnaround
time (TAT) per sample, followed by the QIAcube system and
theMICROLABNimbus IVD system.TheMICROLABNim-
bus IVD systemwas suitable for the downstream applications
as it had the highest sample capacity and the automated PCR
setup function.
3.4. Analytical Sensitivity of the Three Automated Nucleic
Acid Extraction Systems. The analytical sensitivity of the
3 automated nucleic acid extraction systems is showed in
Table 4.The EZ1 Advanced XL system demonstrated the best
analytical sensitivity for all 3 of the viral strains. There was
little difference between the QIAcube and the MICROLAB
Nimbus IVD systems with regards to analytical sensitivity.
4. Discussion
If a specimen with positive results for the same virus by
more than 2 of 3 systems was used as the “gold standard,”
the performance of the QIAcube system was superior to the
EZ1 Advanced XL system and the MICROLAB Nimbus IVD
system in sensitivity and concordance rate (Table 3). The EZ1
Advanced XL system showed relatively high number of the
discrepant results (𝑛 = 12) and false positives (𝑛 = 7),
especially for ADV (3 false positives). However, it showed
the best analytical sensitivity for ADV-3, FluA, and RSV-A
(Table 4) and as well as the highest sensitivity for ADV in
clinical specimens (Table 3). As the analytical sensitivity of
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the confirming test including the Seeplex RV15 ACE Detec-
tion kit (Seegene) and sequencing analysis could be lower
than Anyplex II RV16 Detection kit (Seegene) [22], some of
these false positive results could include true positive results.
Therefore, we discerned that the EZ1 Advanced XL system
is more suitable for ADV virus detection. The MICROLAB
Nimbus IVD system showed the highest specificity (94.6%,
only two false positives), but it demonstrated the lowest
sensitivity (87.2%) with 6 false negatives (Table 3).
The sample and elution volumes used in this study were
150 𝜇L and 60𝜇L for the QIAcube system, 400 𝜇L and 60 𝜇L
for the EZ1 Advanced XL system, and 600𝜇L and 100 𝜇L
for the MICROLAB Nimbus IVD system, respectively. The
relative concentration ratios of sample volume to elution
volume were 2.5 for the QIAcube system, 6.7 for the EZ1
Advanced XL system, and 6.0 for the MICROLAB Nimbus
IVD system, respectively. We used QIAcube system with
sample volume 150𝜇L and elution volume 60 𝜇L routinely
in our laboratory. Therefore, we adjusted the sample volume
and elution volume in the MICROLAB Nimbus IVD system
and the EZ1 Advanced XL system similarly, but we could not
do this in QIAcube system. Although the QIAcube system
was performed with the lowest sample/elution volume ratio,
it showed the best performance.
Previously, Chan et al. evaluated the performance of the
NucliSens easyMAG (bioMerieux, Marcy l’Etoile, France)
and BioRot 9604 automated nucleic acid extraction systems
(Qiagen) in comparison with the manual QIAamp extrac-
tion method (Qiagen). In their study, these three different
methods were evaluated with different sample volumes and
elution volumes. The relative concentration ratios of the
sample volume to elution volume were 4.5 for the NucliSens
easyMAG, 2.5 for the BioRot 9604, and 1.0–2.3 for themanual
QIAamp, respectively. However, the nucleic acids obtained
by all three methods gave comparable sensitivities in PCR
tests, and the three methods gave comparable viral loads [16]
Therefore, we thought that the relative concentrative effect of
the eluted nucleic acid may have little effect on the results of
RT-PCRbasedmethods. In a previous study, theMagNAPure
Compact machine with the MagNAPure Compact Nucleic
Acid Isolation Kit I (Roche, Indianapolis, IN, USA) demon-
strated more than 4-fold higher DNA recovery from the S.
pyogenes than the other automated extraction systems includ-
ing KingFisher-ML (ThermoFisher Scientific Inc., Worcester,
MA, USA), Biorobot EZ1 (Qiagen), easyMAG (bioMerieux),
and Biorobot MDX (Qiagen); however, it was less efficient in
RNA purification from RSV and influenza A virus viruses.
This may be due to RNA degradation or inefficient RNA
binding to themagnetic beads [17]. Actually, theMagNAPure
Compact Nucleic Acid Isolation Kit I was preferred for DNA
extraction, although it did not include carriedRNA. Inclusion
of carried RNA could enhance the yield of a very few target
molecules and reduce the chances of viral RNA degradation.
In our study, all three extraction kits included carried RNA,
and all three systems showed comparable efficiencies of RNA
and DNA extraction (Table 4).
Turnaround time (TAT) per sample of the QIAcube
system, EZ1 Advanced XL, and the MICROLAB Nimbus
IVD systems were 7.5 minutes, 3.2 minutes, and 3.1 minutes,
respectively. Nucleic acid extraction systems using the mag-
netic particle principle had the shorter TAT per sample
than the system which employs the spin column principle,
probably due to its simplicity to perform [23].
Therefore, the systems using the magnetic particle may
be more preferred for more rapid identification of the viral
pathogens. The longer hands-on time of the MICROLAB
Nimbus IVD systems was drawback, but it has the capability
to run 3-4 fold more samples than other comparison systems
at the same time and this system integrates fully automated
steps fromnucleic extraction to PCR setup function, allowing
human errors to be minimized and providing more reliable
results.This system is more suitable for laboratory which was
carried on large samples for PCR.
5. Conclusion
In the present study, the QIAcube system showed the fewest
false negative results and the best concordance rate, and it
may be more suitable for detecting various viruses, including
RNA and DNA virus strains. However, each system demon-
strated different sensitivity and specificity for the detection of
certain viral pathogens and different characteristics such as
the carrier RNA, TAT, sample capacity, and automated PCR
setup function. Therefore, according to the characteristics
of the target patient group and the laboratory, these factors
should be considered when the new nucleic acid extraction
system is introduced into the laboratory.
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